BANK OF MONTREAL /CAN/ - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 253 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$1,912,980
+220.4%
478,245
+3253.8%
0.00%
Q1 2022$597,000
-11.8%
14,260
-4.3%
0.00%
Q4 2021$677,000
-94.8%
14,900
-94.0%
0.00%
-100.0%
Q3 2021$13,118,000
-10.0%
249,818
+9.7%
0.01%
-14.3%
Q2 2021$14,573,000
+880.7%
227,646
+1103.4%
0.01%
+600.0%
Q1 2021$1,486,000
-40.8%
18,917
-25.5%
0.00%
-50.0%
Q4 2020$2,511,000
-70.2%
25,390
-66.5%
0.00%
-71.4%
Q3 2020$8,440,000
-10.5%
75,815
-24.0%
0.01%
-22.2%
Q2 2020$9,425,000
+45.7%
99,759
-12.1%
0.01%
+28.6%
Q1 2020$6,470,000
+34.3%
113,441
+27.0%
0.01%
+75.0%
Q4 2019$4,817,000
+47.0%
89,291
+42.4%
0.00%
+33.3%
Q3 2019$3,277,000
+36.0%
62,693
+25.6%
0.00%
+50.0%
Q2 2019$2,410,000
-35.9%
49,896
-33.0%
0.00%
-33.3%
Q1 2019$3,762,000
-17.4%
74,457
-3.1%
0.00%
-25.0%
Q4 2018$4,555,000
-21.7%
76,852
-13.0%
0.00%
-20.0%
Q3 2018$5,816,000
+64.7%
88,357
+26.3%
0.01%
+66.7%
Q2 2018$3,532,000
-28.5%
69,943
-25.5%
0.00%
-25.0%
Q1 2018$4,940,000
+12.5%
93,826
-0.7%
0.00%0.0%
Q4 2017$4,390,000
+18.9%
94,445
+3.5%
0.00%
+33.3%
Q3 2017$3,693,000
+24.3%
91,282
+4.2%
0.00%0.0%
Q2 2017$2,970,000
-9.7%
87,576
-22.6%
0.00%0.0%
Q1 2017$3,288,000
+9.0%
113,198
+0.4%
0.00%0.0%
Q4 2016$3,017,000
+72.4%
112,725
+103.0%
0.00%
+50.0%
Q3 2016$1,750,000
-1.6%
55,528
-12.2%
0.00%0.0%
Q2 2016$1,778,000
-26.5%
63,246
-5.0%
0.00%
-33.3%
Q1 2016$2,420,000
-35.0%
66,580
-28.5%
0.00%
-25.0%
Q4 2015$3,725,000
+528.2%
93,100
+346.9%
0.00%
+300.0%
Q3 2015$593,000
-20.1%
20,834
-7.5%
0.00%0.0%
Q2 2015$742,000
+18.7%
22,521
+3.6%
0.00%0.0%
Q1 2015$625,000
+2.8%
21,729
-2.7%
0.00%0.0%
Q4 2014$608,000
+28.8%
22,330
+0.7%
0.00%0.0%
Q3 2014$472,000
-8.7%
22,169
-3.9%
0.00%0.0%
Q2 2014$517,000
+28.9%
23,073
+45.0%
0.00%0.0%
Q1 2014$401,000
+36.4%
15,908
+24.2%
0.00%
Q4 2013$294,000
-29.2%
12,807
-41.3%
0.00%
-100.0%
Q3 2013$415,000
+123.1%
21,800
+69.2%
0.00%
Q2 2013$186,00012,8820.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Zebra Capital Management LLC 22,111$908,0002.08%
Global Alpha Capital Management Ltd. 460,530$18,909,0001.62%
AIMZ Investment Advisors, LLC 70,625$2,900,0001.19%
Bridge City Capital, LLC 39,835$1,636,0000.76%
PALISADE CAPITAL MANAGEMENT, LP 560,409$23,010,0000.53%
EARNEST PARTNERS LLC 2,071,376$85,051,0000.50%
RICE HALL JAMES & ASSOCIATES, LLC 302,721$12,430,0000.50%
SummerHaven Investment Management, LLC 14,476$594,0000.34%
Ridgewood Investments LLC 10,004$411,0000.27%
AtonRa Partners 11,505$472,0000.26%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders